nach oben

International Journal of Diabetes in Developing Countries

Erschienen in:

01.12.2011 | Original Article

Prevalence of the metabolic syndrome in rural India—a disparity in definitions

verfasst von: Punith Kempegowda, Sara Rani Marcus, Priyank Solanki, Rashmi S. Reddy, Nandini D. R., Mala Dharmalingam

Erschienen in: International Journal of Diabetes in Developing Countries | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

Although the metabolic syndrome is a known predictor of coronary heart disease and type-2 diabetes mellitus, it has no agreed definition. The concordance of its various definitions has been studied for a limited number of populations and there are few studies on the rural populations in India. The present study was done to determine the prevalence of metabolic syndrome in a rural population of South India and to evaluate the concordance of the modified National Cholesterol Education Programme-Adult Treatment Panel III definition and International Diabetes Federation definition for the diagnosis of Metabolic Syndrome. Anthropometric and biochemical parameters (fasting blood glucose and lipid profile) and blood pressure were measured using standard procedures. The prevalence of metabolic syndrome was calculated using the two sets of criteria and compared for their concordance. Descriptive statistics was used to analyze age and risk factors of metabolic syndrome. The chi-square test was applied to compare the prevalence of metabolic syndrome obtained from the two criteria (significant if p < 0.05). An inter-rater reliability analysis using the kappa statistic was performed to determine consistency between the two sets of criteria in diagnosing the metabolic syndrome. The modified National Cholesterol Education Programme-Adult Treatment Panel III definition and International Diabetes Federation definition for metabolic syndrome identified overall age-adjusted prevalence of 17.8% and 20.5% respectively, which were not significantly different. Kappa statistics revealed only moderate agreement of 0.44 between the two sets of criteria. The impact of economic development and preponderance of genetic factors is increasing the prevalence of metabolic syndrome in rural India. It is important to determine which definition of the metabolic syndrome best predicts coronary heart disease and type 2 diabetes in this population in order to formulate effective public health policy.

National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143–421.

Reddy KS, Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation. 1998;97:596–601.PubMed

Ghaffar A, Reddy KS, Singhi M. Burden of non-communicable diseases in South Asia. BMJ. 2004;328:807–10.PubMedCrossRef

Joshi R, Cardona M, Iyengar S, Sukumar A, Raju CR, Raju KR, et al. Chronic diseases now a leading cause of death in rural India—mortality data from Andhra Pradesh Health Initiative. Int J Epidemiol. 2006;35:1522–9.PubMedCrossRef

World health Organization. NCMH Background papers-Disease burden in India Estimations and causal analysis. New Delhi (India), Ministry of Health and family Welfare, 2005. Available from http://www.whoindia.org/LinkFiles/Commision_on_Macroeconomic_and_Health_Bg_P2_Burden_of_Disease_Estimations_and_Casual_analysis.pdf.

Deepa M, Farooq S, Datta M, Deepa R, Mohan V. Prevalence of metabolic syndrome using WHO, ATPIII and IDF definitions in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-34). Diabetes Metab Res Rev. 2007;23:127–34.PubMedCrossRef

Prabhakaran D, Chaturvedi V, Shah P, Manhapra A, Jeemon P, Shah B, et al. Differences in the prevalence of metabolic syndrome in urban and rural India: a problem of urbanization. Chronic Illn. 2007;3:8–19.PubMedCrossRef

World Health Organization: Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus. Geneva, World Health Organization, 1999. Available from http://www.staff.ncl.ac.uk/philip.home/who_dmg.pdf.

Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med. 1999;16:442–3.PubMedCrossRef

10.

Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2486–97.CrossRef

11.

Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735–52.PubMedCrossRef

12.

Alberti KG, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group. The metabolic syndrome—a new worldwide definition. Lancet. 2005;366:1059–62.PubMedCrossRef

13.

Lee CM, Huxley RR, Woodward M, Zimmet P, Shaw J, Cho NH, et al. Detect-2 collaboration: Comparisons of metabolic syndrome definitions in four populations of the Asia-Pacific region. Metab Syndr Relat Disord. 2008;6:37–46.PubMedCrossRef

14.

Guerrero-Romero F, Rodríguez-Morán M. Concordance between the 2005 International Diabetes Federation definition for diagnosing metabolic syndrome with the National Cholesterol Education Program Adult Treatment Panel III and the World Health Organization definitions. Diabetes Care. 2005;28:2588–9.PubMedCrossRef

15.

Can AS, Bersot TP. Analysis of agreement among definitions of metabolic syndrome in nondiabetic Turkish adults: a methodological study. BMC Publ Health. 2007;19:353.CrossRef

16.

Kelliny C, William J, Riesen W, Bovet P. Metabolic syndrome according to different definitions in a rapidly developing country of the African region. Cardiovasc Diabetol. 2008;7:27.PubMedCrossRef

17.

Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–74.PubMedCrossRef

18.

Mahadik SR, Deo SS, Mehtalia SD. Increased prevalence of metabolic syndrome in non-obese Asian Indian—an urban-rural comparison. Metab Syndr Relat Disord. 2007;5:142–52.PubMedCrossRef

19.

Qiao Q, DECODE Study Group. Comparison of different definitions of the metabolic syndrome in relation to cardiovascular mortality in European men and women. Diabetologia. 2006;49:2837–46.PubMedCrossRef

20.

Balkau B. The DECODE study. Diabetes epidemiology: collaborative analysis of diagnostic criteria in Europe. Diabetes Metab. 2000;26:282–6.PubMed

21.

Adegoke OA, Adedoyin RA, Balogun MO, Adebayo RA, Bisiriyu LA, Salawu AA. Prevalence of metabolic syndrome in a rural community in Nigeria. Metab Syndr Relat Disord. 2010;8:59–62.PubMedCrossRef

22.

Vaughan C, Schoo A, Janus ED, Philpot B, Davis-Lameloise N, Lo SK, et al. The association of levels of physical activity with metabolic syndrome in rural Australian adults. BMC Publ Health. 2009;9:273.CrossRef

23.

Redmon JB, Bertoni AG, Connelly S, Fenney PA, Glasser S, Glick H, et al. Effect of the Look AHEAD Study intervention on medication use and related cost to treat cardiovascular disease risk factors in individuals with type 2 diabetes. Diabetes Care. 2010;33:1153–8.PubMedCrossRef

24.

Misra A, Khurana L. The metabolic syndrome in South Asians: epidemiology, determinants, and prevention. Metab Syndr Relat Disord. 2009;7:497–514.PubMedCrossRef

25.

Enas EA, Mohan V, Deepa M, Farooq S, Pazhoor S, Chennikkara H. The metabolic syndrome and dyslipidemia among Asian Indians: a population with high rates of diabetes and premature coronary artery disease. J Cardiometab Syndr. 2007;2:267–75.PubMedCrossRef

26.

Morimoto A, Nishimura R, Suzuki N, Matsudaira T, Taki K, Tsujino D, et al. Low prevalence of metabolic syndrome and its components in rural Japan. Tohoku J Exp Med. 2008;216:69–75.PubMedCrossRef

27.

Zuo H, Shi Z, Hu X, Wu M, Guo Z, Hussain A. Prevalence of metabolic syndrome and factors associated with its components in Chinese adults. Metabolism. 2009;58:1102–8.PubMedCrossRef

28.

Ntandou G, Delisle H, Agueh V, Fayomi B. Abdominal obesity explains the positive rural-urban gradient in the prevalence of the metabolic syndrome in Benin, West Africa. Nutr Res. 2009;29:180–9.PubMedCrossRef

29.

Basit A, Shera AS. Prevalence of metabolic syndrome in Pakistan. Metab Syndr Relat Disord. 2008;6:171–5.PubMedCrossRef

30.

Chow CK, Naidu S, Raju K, Raju R, Joshi R, Sullivan D, et al. Significant lipid, adiposity and metabolic abnormalities amongst 4535 Indians from a developing region of rural Andhra Pradesh. Atherosclerosis. 2008;196:943–52.PubMedCrossRef

31.

Rahim MA, Khan AK, Sayeed MA, Akhtar B, Nahar Q, Ali SMK, et al. Metabolic syndrome in rural Bangladesh: comparison of newly proposed IDF, modified ATP III and WHO criteria and their agreements. Diabetes Metab Syndr Clin Res Rev. 2007;1:251–7.CrossRef

32.

Hydrie MZ, Shera AS, Fawwad A, Basit A, Hussain A. Prevalence of metabolic syndrome in urban Pakistan (Karachi): comparison of newly proposed International Diabetes Federation and modified Adult Treatment Panel III criteria. Metab Syndr Relat Disord. 2009;7:119–24.PubMedCrossRef

33.

Mangat C, Goel NK, Walia DK, Agarwal N, Sharma MK, Kaur J, et al. Metabolic syndrome: a challenging health issue in highly urbanized Union territory of North India. Diabetol Metab Syndr. 2010;2:19.PubMedCrossRef

Titel: Prevalence of the metabolic syndrome in rural India—a disparity in definitions
verfasst von: Punith Kempegowda
Sara Rani Marcus
Priyank Solanki
Rashmi S. Reddy
Nandini D. R.
Mala Dharmalingam
Publikationsdatum: 01.12.2011
Verlag: Springer-Verlag
Erschienen in: International Journal of Diabetes in Developing Countries / Ausgabe 4/2011
Print ISSN: 0973-3930
Elektronische ISSN: 1998-3832
DOI: https://doi.org/10.1007/s13410-011-0046-y

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2011

Relationship between limited joint mobility syndrome and duration, metabolic control, complications of diabetes as well as effects of the syndrome on quality of life

Switching to three pre-meal injections of insulin glulisine from the basal-bolus insulin therapy improves glycemic control in a patient with type 2 diabetes who had anti-insulin antibody

Glycemic and insulinemic responses to breakfast and succeeding second meal in type 2 diabetics

Pseudoainhum of toes in type 2 diabetes

Are low dose pioglitazone combinations justifiable?

Salivary total antioxidant capacity in type 2 diabetes mellitus patients—a clinical and biochemical study amongst tobacco smokers